nodes	percent_of_prediction	percent_of_DWPC	metapath
Hexylcaine—Oxybutynin—CYP3A5—prostate cancer	0.0103	0.358	CrCbGaD
Hexylcaine—Cocaine—CYP3A5—prostate cancer	0.00972	0.34	CrCbGaD
Hexylcaine—Oxybutynin—CYP3A4—prostate cancer	0.00444	0.155	CrCbGaD
Hexylcaine—Cocaine—CYP3A4—prostate cancer	0.00421	0.147	CrCbGaD
Hexylcaine—SCN5A—Cardiac Progenitor Differentiation—TGFB1—prostate cancer	0.00192	0.00198	CbGpPWpGaD
Hexylcaine—SCN1A—Developmental Biology—NCOA3—prostate cancer	0.00191	0.00196	CbGpPWpGaD
Hexylcaine—SCN10A—Developmental Biology—NCOA3—prostate cancer	0.00191	0.00196	CbGpPWpGaD
Hexylcaine—SCN10A—L1CAM interactions—SRC—prostate cancer	0.0019	0.00195	CbGpPWpGaD
Hexylcaine—SCN1A—L1CAM interactions—SRC—prostate cancer	0.0019	0.00195	CbGpPWpGaD
Hexylcaine—SCN10A—Axon guidance—PRKCQ—prostate cancer	0.00189	0.00195	CbGpPWpGaD
Hexylcaine—SCN1A—Axon guidance—PRKCQ—prostate cancer	0.00189	0.00195	CbGpPWpGaD
Hexylcaine—SCN5A—Developmental Biology—EZR—prostate cancer	0.00188	0.00194	CbGpPWpGaD
Hexylcaine—SCN3A—Axon guidance—VAV3—prostate cancer	0.00188	0.00193	CbGpPWpGaD
Hexylcaine—SCN5A—SIDS Susceptibility Pathways—NR3C1—prostate cancer	0.00184	0.00189	CbGpPWpGaD
Hexylcaine—SCN2A—Axon guidance—VAV3—prostate cancer	0.0018	0.00185	CbGpPWpGaD
Hexylcaine—SCN3A—L1CAM interactions—EGFR—prostate cancer	0.0018	0.00185	CbGpPWpGaD
Hexylcaine—SCN10A—Axon guidance—VAV3—prostate cancer	0.00174	0.00179	CbGpPWpGaD
Hexylcaine—SCN1A—Axon guidance—VAV3—prostate cancer	0.00174	0.00179	CbGpPWpGaD
Hexylcaine—SCN2A—L1CAM interactions—EGFR—prostate cancer	0.00173	0.00178	CbGpPWpGaD
Hexylcaine—SCN5A—Developmental Biology—HNF1B—prostate cancer	0.00172	0.00177	CbGpPWpGaD
Hexylcaine—SCN5A—Developmental Biology—NRP1—prostate cancer	0.00172	0.00177	CbGpPWpGaD
Hexylcaine—SCN3A—Developmental Biology—NCOA2—prostate cancer	0.00172	0.00177	CbGpPWpGaD
Hexylcaine—SCN5A—SIDS Susceptibility Pathways—HIF1A—prostate cancer	0.00167	0.00172	CbGpPWpGaD
Hexylcaine—SCN10A—L1CAM interactions—EGFR—prostate cancer	0.00166	0.00171	CbGpPWpGaD
Hexylcaine—SCN1A—L1CAM interactions—EGFR—prostate cancer	0.00166	0.00171	CbGpPWpGaD
Hexylcaine—SCN2A—Developmental Biology—NCOA2—prostate cancer	0.00165	0.0017	CbGpPWpGaD
Hexylcaine—SCN3A—Axon guidance—ITGB3—prostate cancer	0.00161	0.00166	CbGpPWpGaD
Hexylcaine—SCN1A—Developmental Biology—NCOA2—prostate cancer	0.00159	0.00164	CbGpPWpGaD
Hexylcaine—SCN10A—Developmental Biology—NCOA2—prostate cancer	0.00159	0.00164	CbGpPWpGaD
Hexylcaine—SCN5A—Developmental Biology—HSP90AB1—prostate cancer	0.00156	0.00161	CbGpPWpGaD
Hexylcaine—SCN2A—Axon guidance—ITGB3—prostate cancer	0.00155	0.00159	CbGpPWpGaD
Hexylcaine—SCN1A—Axon guidance—ITGB3—prostate cancer	0.00149	0.00154	CbGpPWpGaD
Hexylcaine—SCN10A—Axon guidance—ITGB3—prostate cancer	0.00149	0.00154	CbGpPWpGaD
Hexylcaine—SCN3A—Developmental Biology—PRKCQ—prostate cancer	0.00146	0.0015	CbGpPWpGaD
Hexylcaine—SCN3A—Developmental Biology—NCOA1—prostate cancer	0.00145	0.00149	CbGpPWpGaD
Hexylcaine—SCN5A—Developmental Biology—PRNP—prostate cancer	0.00142	0.00147	CbGpPWpGaD
Hexylcaine—SCN2A—Developmental Biology—PRKCQ—prostate cancer	0.0014	0.00144	CbGpPWpGaD
Hexylcaine—SCN5A—Developmental Biology—MED12—prostate cancer	0.0014	0.00144	CbGpPWpGaD
Hexylcaine—SCN2A—Developmental Biology—NCOA1—prostate cancer	0.00139	0.00143	CbGpPWpGaD
Hexylcaine—SCN3A—Developmental Biology—FGF10—prostate cancer	0.00139	0.00143	CbGpPWpGaD
Hexylcaine—SCN3A—Developmental Biology—RXRA—prostate cancer	0.00138	0.00142	CbGpPWpGaD
Hexylcaine—SCN3A—Axon guidance—KDR—prostate cancer	0.00137	0.00141	CbGpPWpGaD
Hexylcaine—SCN5A—SIDS Susceptibility Pathways—CREBBP—prostate cancer	0.00137	0.00141	CbGpPWpGaD
Hexylcaine—SCN10A—Developmental Biology—PRKCQ—prostate cancer	0.00135	0.00139	CbGpPWpGaD
Hexylcaine—SCN1A—Developmental Biology—PRKCQ—prostate cancer	0.00135	0.00139	CbGpPWpGaD
Hexylcaine—SCN1A—Developmental Biology—NCOA1—prostate cancer	0.00134	0.00138	CbGpPWpGaD
Hexylcaine—SCN10A—Developmental Biology—NCOA1—prostate cancer	0.00134	0.00138	CbGpPWpGaD
Hexylcaine—SCN5A—Developmental Biology—NCOA3—prostate cancer	0.00134	0.00138	CbGpPWpGaD
Hexylcaine—SCN3A—Developmental Biology—VAV3—prostate cancer	0.00134	0.00138	CbGpPWpGaD
Hexylcaine—SCN5A—L1CAM interactions—SRC—prostate cancer	0.00133	0.00137	CbGpPWpGaD
Hexylcaine—SCN2A—Developmental Biology—FGF10—prostate cancer	0.00133	0.00137	CbGpPWpGaD
Hexylcaine—SCN5A—Axon guidance—PRKCQ—prostate cancer	0.00133	0.00137	CbGpPWpGaD
Hexylcaine—SCN2A—Developmental Biology—RXRA—prostate cancer	0.00132	0.00136	CbGpPWpGaD
Hexylcaine—SCN2A—Axon guidance—KDR—prostate cancer	0.00132	0.00135	CbGpPWpGaD
Hexylcaine—SCN2A—Developmental Biology—VAV3—prostate cancer	0.00129	0.00132	CbGpPWpGaD
Hexylcaine—SCN1A—Developmental Biology—FGF10—prostate cancer	0.00128	0.00132	CbGpPWpGaD
Hexylcaine—SCN10A—Developmental Biology—FGF10—prostate cancer	0.00128	0.00132	CbGpPWpGaD
Hexylcaine—SCN10A—Developmental Biology—RXRA—prostate cancer	0.00127	0.00131	CbGpPWpGaD
Hexylcaine—SCN1A—Developmental Biology—RXRA—prostate cancer	0.00127	0.00131	CbGpPWpGaD
Hexylcaine—SCN1A—Axon guidance—KDR—prostate cancer	0.00127	0.00131	CbGpPWpGaD
Hexylcaine—SCN10A—Axon guidance—KDR—prostate cancer	0.00127	0.00131	CbGpPWpGaD
Hexylcaine—SCN10A—Developmental Biology—VAV3—prostate cancer	0.00124	0.00128	CbGpPWpGaD
Hexylcaine—SCN1A—Developmental Biology—VAV3—prostate cancer	0.00124	0.00128	CbGpPWpGaD
Hexylcaine—SCN5A—Axon guidance—VAV3—prostate cancer	0.00122	0.00126	CbGpPWpGaD
Hexylcaine—SCN3A—Axon guidance—GSK3B—prostate cancer	0.00121	0.00125	CbGpPWpGaD
Hexylcaine—SCN3A—Developmental Biology—LPL—prostate cancer	0.00119	0.00122	CbGpPWpGaD
Hexylcaine—SCN5A—L1CAM interactions—EGFR—prostate cancer	0.00117	0.0012	CbGpPWpGaD
Hexylcaine—SCN2A—Axon guidance—GSK3B—prostate cancer	0.00116	0.0012	CbGpPWpGaD
Hexylcaine—SCN3A—Developmental Biology—ITGB3—prostate cancer	0.00115	0.00118	CbGpPWpGaD
Hexylcaine—SCN2A—Developmental Biology—LPL—prostate cancer	0.00114	0.00118	CbGpPWpGaD
Hexylcaine—SCN10A—Axon guidance—GSK3B—prostate cancer	0.00112	0.00115	CbGpPWpGaD
Hexylcaine—SCN1A—Axon guidance—GSK3B—prostate cancer	0.00112	0.00115	CbGpPWpGaD
Hexylcaine—SCN5A—Developmental Biology—NCOA2—prostate cancer	0.00112	0.00115	CbGpPWpGaD
Hexylcaine—SCN3A—Axon guidance—MMP2—prostate cancer	0.00112	0.00115	CbGpPWpGaD
Hexylcaine—SCN3A—Axon guidance—MAP2K1—prostate cancer	0.00112	0.00115	CbGpPWpGaD
Hexylcaine—SCN2A—Developmental Biology—ITGB3—prostate cancer	0.0011	0.00114	CbGpPWpGaD
Hexylcaine—SCN10A—Developmental Biology—LPL—prostate cancer	0.0011	0.00113	CbGpPWpGaD
Hexylcaine—SCN1A—Developmental Biology—LPL—prostate cancer	0.0011	0.00113	CbGpPWpGaD
Hexylcaine—SCN5A—SIDS Susceptibility Pathways—CXCL8—prostate cancer	0.00109	0.00112	CbGpPWpGaD
Hexylcaine—SCN2A—Axon guidance—MMP2—prostate cancer	0.00107	0.00111	CbGpPWpGaD
Hexylcaine—SCN2A—Axon guidance—MAP2K1—prostate cancer	0.00107	0.0011	CbGpPWpGaD
Hexylcaine—SCN10A—Developmental Biology—ITGB3—prostate cancer	0.00106	0.0011	CbGpPWpGaD
Hexylcaine—SCN1A—Developmental Biology—ITGB3—prostate cancer	0.00106	0.0011	CbGpPWpGaD
Hexylcaine—SCN3A—Developmental Biology—PPARA—prostate cancer	0.00105	0.00108	CbGpPWpGaD
Hexylcaine—SCN5A—Axon guidance—ITGB3—prostate cancer	0.00105	0.00108	CbGpPWpGaD
Hexylcaine—SCN5A—SIDS Susceptibility Pathways—CASP3—prostate cancer	0.00104	0.00107	CbGpPWpGaD
Hexylcaine—SCN10A—Axon guidance—MMP2—prostate cancer	0.00104	0.00107	CbGpPWpGaD
Hexylcaine—SCN1A—Axon guidance—MMP2—prostate cancer	0.00104	0.00107	CbGpPWpGaD
Hexylcaine—SCN10A—Axon guidance—MAP2K1—prostate cancer	0.00103	0.00106	CbGpPWpGaD
Hexylcaine—SCN1A—Axon guidance—MAP2K1—prostate cancer	0.00103	0.00106	CbGpPWpGaD
Hexylcaine—SCN3A—Axon guidance—JAK2—prostate cancer	0.00102	0.00105	CbGpPWpGaD
Hexylcaine—SCN2A—Developmental Biology—PPARA—prostate cancer	0.00101	0.00104	CbGpPWpGaD
Hexylcaine—SCN5A—SIDS Susceptibility Pathways—CTNNB1—prostate cancer	0.001	0.00103	CbGpPWpGaD
Hexylcaine—SCN3A—Developmental Biology—LEP—prostate cancer	0.000997	0.00103	CbGpPWpGaD
Hexylcaine—SCN3A—Axon guidance—ERBB2—prostate cancer	0.000979	0.00101	CbGpPWpGaD
Hexylcaine—SCN2A—Axon guidance—JAK2—prostate cancer	0.000978	0.00101	CbGpPWpGaD
Hexylcaine—SCN3A—Developmental Biology—KDR—prostate cancer	0.000977	0.00101	CbGpPWpGaD
Hexylcaine—SCN1A—Developmental Biology—PPARA—prostate cancer	0.000974	0.001	CbGpPWpGaD
Hexylcaine—SCN10A—Developmental Biology—PPARA—prostate cancer	0.000974	0.001	CbGpPWpGaD
Hexylcaine—SCN2A—Developmental Biology—LEP—prostate cancer	0.000958	0.000986	CbGpPWpGaD
Hexylcaine—SCN5A—Developmental Biology—PRKCQ—prostate cancer	0.000951	0.000979	CbGpPWpGaD
Hexylcaine—SCN1A—Axon guidance—JAK2—prostate cancer	0.000943	0.000971	CbGpPWpGaD
Hexylcaine—SCN10A—Axon guidance—JAK2—prostate cancer	0.000943	0.000971	CbGpPWpGaD
Hexylcaine—SCN5A—Developmental Biology—NCOA1—prostate cancer	0.000942	0.00097	CbGpPWpGaD
Hexylcaine—SCN2A—Axon guidance—ERBB2—prostate cancer	0.000941	0.000969	CbGpPWpGaD
Hexylcaine—SCN2A—Developmental Biology—KDR—prostate cancer	0.000939	0.000966	CbGpPWpGaD
Hexylcaine—SCN5A—SIDS Susceptibility Pathways—EP300—prostate cancer	0.000931	0.000958	CbGpPWpGaD
Hexylcaine—SCN1A—Developmental Biology—LEP—prostate cancer	0.000924	0.000951	CbGpPWpGaD
Hexylcaine—SCN10A—Developmental Biology—LEP—prostate cancer	0.000924	0.000951	CbGpPWpGaD
Hexylcaine—SCN1A—Axon guidance—ERBB2—prostate cancer	0.000907	0.000934	CbGpPWpGaD
Hexylcaine—SCN10A—Axon guidance—ERBB2—prostate cancer	0.000907	0.000934	CbGpPWpGaD
Hexylcaine—SCN10A—Developmental Biology—KDR—prostate cancer	0.000905	0.000932	CbGpPWpGaD
Hexylcaine—SCN1A—Developmental Biology—KDR—prostate cancer	0.000905	0.000932	CbGpPWpGaD
Hexylcaine—SCN5A—Developmental Biology—FGF10—prostate cancer	0.000903	0.00093	CbGpPWpGaD
Hexylcaine—SCN5A—Developmental Biology—RXRA—prostate cancer	0.000896	0.000922	CbGpPWpGaD
Hexylcaine—SCN5A—Axon guidance—KDR—prostate cancer	0.000892	0.000918	CbGpPWpGaD
Hexylcaine—SCN5A—SIDS Susceptibility Pathways—VEGFA—prostate cancer	0.000882	0.000908	CbGpPWpGaD
Hexylcaine—SCN5A—Developmental Biology—VAV3—prostate cancer	0.000872	0.000897	CbGpPWpGaD
Hexylcaine—SCN3A—Developmental Biology—GSK3B—prostate cancer	0.000864	0.000889	CbGpPWpGaD
Hexylcaine—SCN3A—Developmental Biology—INS—prostate cancer	0.000852	0.000877	CbGpPWpGaD
Hexylcaine—SCN3A—Axon guidance—MMP9—prostate cancer	0.00084	0.000865	CbGpPWpGaD
Hexylcaine—SCN3A—Developmental Biology—CREBBP—prostate cancer	0.000834	0.000859	CbGpPWpGaD
Hexylcaine—SCN2A—Developmental Biology—GSK3B—prostate cancer	0.00083	0.000854	CbGpPWpGaD
Hexylcaine—SCN2A—Developmental Biology—INS—prostate cancer	0.000819	0.000843	CbGpPWpGaD
Hexylcaine—SCN2A—Axon guidance—MMP9—prostate cancer	0.000807	0.000831	CbGpPWpGaD
Hexylcaine—SCN2A—Developmental Biology—CREBBP—prostate cancer	0.000802	0.000825	CbGpPWpGaD
Hexylcaine—SCN10A—Developmental Biology—GSK3B—prostate cancer	0.0008	0.000824	CbGpPWpGaD
Hexylcaine—SCN1A—Developmental Biology—GSK3B—prostate cancer	0.0008	0.000824	CbGpPWpGaD
Hexylcaine—SCN3A—Developmental Biology—MMP2—prostate cancer	0.000798	0.000821	CbGpPWpGaD
Hexylcaine—SCN3A—Developmental Biology—MAP2K1—prostate cancer	0.000796	0.00082	CbGpPWpGaD
Hexylcaine—SCN10A—Developmental Biology—INS—prostate cancer	0.000789	0.000813	CbGpPWpGaD
Hexylcaine—SCN1A—Developmental Biology—INS—prostate cancer	0.000789	0.000813	CbGpPWpGaD
Hexylcaine—SCN5A—Axon guidance—GSK3B—prostate cancer	0.000788	0.000812	CbGpPWpGaD
Hexylcaine—SCN10A—Axon guidance—MMP9—prostate cancer	0.000778	0.000801	CbGpPWpGaD
Hexylcaine—SCN1A—Axon guidance—MMP9—prostate cancer	0.000778	0.000801	CbGpPWpGaD
Hexylcaine—SCN5A—Developmental Biology—LPL—prostate cancer	0.000775	0.000798	CbGpPWpGaD
Hexylcaine—SCN3A—Axon guidance—SRC—prostate cancer	0.000774	0.000797	CbGpPWpGaD
Hexylcaine—SCN10A—Developmental Biology—CREBBP—prostate cancer	0.000773	0.000796	CbGpPWpGaD
Hexylcaine—SCN1A—Developmental Biology—CREBBP—prostate cancer	0.000773	0.000796	CbGpPWpGaD
Hexylcaine—SCN2A—Developmental Biology—MMP2—prostate cancer	0.000766	0.000789	CbGpPWpGaD
Hexylcaine—SCN2A—Developmental Biology—MAP2K1—prostate cancer	0.000765	0.000788	CbGpPWpGaD
Hexylcaine—SCN3A—Developmental Biology—FGF2—prostate cancer	0.000758	0.00078	CbGpPWpGaD
Hexylcaine—SCN3A—Axon guidance—VEGFA—prostate cancer	0.000754	0.000777	CbGpPWpGaD
Hexylcaine—SCN5A—Developmental Biology—ITGB3—prostate cancer	0.000748	0.00077	CbGpPWpGaD
Hexylcaine—SCN2A—Axon guidance—SRC—prostate cancer	0.000744	0.000766	CbGpPWpGaD
Hexylcaine—SCN10A—Developmental Biology—MMP2—prostate cancer	0.000739	0.000761	CbGpPWpGaD
Hexylcaine—SCN1A—Developmental Biology—MMP2—prostate cancer	0.000739	0.000761	CbGpPWpGaD
Hexylcaine—SCN1A—Developmental Biology—MAP2K1—prostate cancer	0.000738	0.00076	CbGpPWpGaD
Hexylcaine—SCN10A—Developmental Biology—MAP2K1—prostate cancer	0.000738	0.00076	CbGpPWpGaD
Hexylcaine—SCN5A—Axon guidance—MMP2—prostate cancer	0.000728	0.000749	CbGpPWpGaD
Hexylcaine—SCN2A—Developmental Biology—FGF2—prostate cancer	0.000728	0.000749	CbGpPWpGaD
Hexylcaine—SCN5A—Axon guidance—MAP2K1—prostate cancer	0.000727	0.000748	CbGpPWpGaD
Hexylcaine—SCN3A—Developmental Biology—JAK2—prostate cancer	0.000726	0.000748	CbGpPWpGaD
Hexylcaine—SCN2A—Axon guidance—VEGFA—prostate cancer	0.000725	0.000746	CbGpPWpGaD
Hexylcaine—SCN10A—Axon guidance—SRC—prostate cancer	0.000718	0.000739	CbGpPWpGaD
Hexylcaine—SCN1A—Axon guidance—SRC—prostate cancer	0.000718	0.000739	CbGpPWpGaD
Hexylcaine—SCN10A—Developmental Biology—FGF2—prostate cancer	0.000702	0.000723	CbGpPWpGaD
Hexylcaine—SCN1A—Developmental Biology—FGF2—prostate cancer	0.000702	0.000723	CbGpPWpGaD
Hexylcaine—SCN3A—Developmental Biology—ERBB2—prostate cancer	0.000699	0.000719	CbGpPWpGaD
Hexylcaine—SCN10A—Axon guidance—VEGFA—prostate cancer	0.000699	0.000719	CbGpPWpGaD
Hexylcaine—SCN1A—Axon guidance—VEGFA—prostate cancer	0.000699	0.000719	CbGpPWpGaD
Hexylcaine—SCN2A—Developmental Biology—JAK2—prostate cancer	0.000698	0.000718	CbGpPWpGaD
Hexylcaine—SCN5A—Developmental Biology—PPARA—prostate cancer	0.000685	0.000705	CbGpPWpGaD
Hexylcaine—SCN3A—Axon guidance—EGFR—prostate cancer	0.000679	0.000699	CbGpPWpGaD
Hexylcaine—SCN10A—Developmental Biology—JAK2—prostate cancer	0.000673	0.000693	CbGpPWpGaD
Hexylcaine—SCN1A—Developmental Biology—JAK2—prostate cancer	0.000673	0.000693	CbGpPWpGaD
Hexylcaine—SCN2A—Developmental Biology—ERBB2—prostate cancer	0.000671	0.000691	CbGpPWpGaD
Hexylcaine—SCN5A—Axon guidance—JAK2—prostate cancer	0.000663	0.000682	CbGpPWpGaD
Hexylcaine—SCN2A—Axon guidance—EGFR—prostate cancer	0.000652	0.000671	CbGpPWpGaD
Hexylcaine—SCN5A—Developmental Biology—LEP—prostate cancer	0.00065	0.000669	CbGpPWpGaD
Hexylcaine—SCN10A—Developmental Biology—ERBB2—prostate cancer	0.000647	0.000667	CbGpPWpGaD
Hexylcaine—SCN1A—Developmental Biology—ERBB2—prostate cancer	0.000647	0.000667	CbGpPWpGaD
Hexylcaine—SCN3A—Axon guidance—KRAS—prostate cancer	0.000641	0.00066	CbGpPWpGaD
Hexylcaine—SCN5A—Axon guidance—ERBB2—prostate cancer	0.000638	0.000657	CbGpPWpGaD
Hexylcaine—SCN5A—Developmental Biology—KDR—prostate cancer	0.000636	0.000655	CbGpPWpGaD
Hexylcaine—SCN1A—Axon guidance—EGFR—prostate cancer	0.000629	0.000647	CbGpPWpGaD
Hexylcaine—SCN10A—Axon guidance—EGFR—prostate cancer	0.000629	0.000647	CbGpPWpGaD
Hexylcaine—SCN2A—Axon guidance—KRAS—prostate cancer	0.000616	0.000634	CbGpPWpGaD
Hexylcaine—SCN3A—Developmental Biology—CTNNB1—prostate cancer	0.000611	0.000629	CbGpPWpGaD
Hexylcaine—SCN5A—SIDS Susceptibility Pathways—IL6—prostate cancer	0.00061	0.000628	CbGpPWpGaD
Hexylcaine—SCN3A—Developmental Biology—MMP9—prostate cancer	0.000599	0.000617	CbGpPWpGaD
Hexylcaine—SCN10A—Axon guidance—KRAS—prostate cancer	0.000594	0.000612	CbGpPWpGaD
Hexylcaine—SCN1A—Axon guidance—KRAS—prostate cancer	0.000594	0.000612	CbGpPWpGaD
Hexylcaine—SCN2A—Developmental Biology—CTNNB1—prostate cancer	0.000587	0.000605	CbGpPWpGaD
Hexylcaine—SCN2A—Developmental Biology—MMP9—prostate cancer	0.000576	0.000593	CbGpPWpGaD
Hexylcaine—SCN3A—Developmental Biology—EP300—prostate cancer	0.000568	0.000585	CbGpPWpGaD
Hexylcaine—SCN10A—Developmental Biology—CTNNB1—prostate cancer	0.000566	0.000583	CbGpPWpGaD
Hexylcaine—SCN1A—Developmental Biology—CTNNB1—prostate cancer	0.000566	0.000583	CbGpPWpGaD
Hexylcaine—SCN5A—Developmental Biology—GSK3B—prostate cancer	0.000563	0.000579	CbGpPWpGaD
Hexylcaine—SCN1A—Developmental Biology—MMP9—prostate cancer	0.000555	0.000572	CbGpPWpGaD
Hexylcaine—SCN10A—Developmental Biology—MMP9—prostate cancer	0.000555	0.000572	CbGpPWpGaD
Hexylcaine—SCN5A—Developmental Biology—INS—prostate cancer	0.000555	0.000571	CbGpPWpGaD
Hexylcaine—SCN3A—Developmental Biology—SRC—prostate cancer	0.000553	0.000569	CbGpPWpGaD
Hexylcaine—SCN5A—Axon guidance—MMP9—prostate cancer	0.000547	0.000563	CbGpPWpGaD
Hexylcaine—SCN2A—Developmental Biology—EP300—prostate cancer	0.000546	0.000562	CbGpPWpGaD
Hexylcaine—SCN5A—Developmental Biology—CREBBP—prostate cancer	0.000544	0.00056	CbGpPWpGaD
Hexylcaine—SCN3A—Developmental Biology—VEGFA—prostate cancer	0.000538	0.000554	CbGpPWpGaD
Hexylcaine—SCN3A—Developmental Biology—STAT3—prostate cancer	0.000533	0.000549	CbGpPWpGaD
Hexylcaine—SCN2A—Developmental Biology—SRC—prostate cancer	0.000531	0.000547	CbGpPWpGaD
Hexylcaine—SCN10A—Developmental Biology—EP300—prostate cancer	0.000527	0.000542	CbGpPWpGaD
Hexylcaine—SCN1A—Developmental Biology—EP300—prostate cancer	0.000527	0.000542	CbGpPWpGaD
Hexylcaine—SCN3A—Axon guidance—IL6—prostate cancer	0.000522	0.000537	CbGpPWpGaD
Hexylcaine—SCN5A—Developmental Biology—MMP2—prostate cancer	0.000519	0.000535	CbGpPWpGaD
Hexylcaine—SCN5A—Developmental Biology—MAP2K1—prostate cancer	0.000519	0.000534	CbGpPWpGaD
Hexylcaine—SCN2A—Developmental Biology—VEGFA—prostate cancer	0.000517	0.000532	CbGpPWpGaD
Hexylcaine—SCN2A—Developmental Biology—STAT3—prostate cancer	0.000512	0.000527	CbGpPWpGaD
Hexylcaine—SCN10A—Developmental Biology—SRC—prostate cancer	0.000512	0.000527	CbGpPWpGaD
Hexylcaine—SCN1A—Developmental Biology—SRC—prostate cancer	0.000512	0.000527	CbGpPWpGaD
Hexylcaine—SCN5A—Axon guidance—SRC—prostate cancer	0.000504	0.000519	CbGpPWpGaD
Hexylcaine—SCN2A—Axon guidance—IL6—prostate cancer	0.000501	0.000516	CbGpPWpGaD
Hexylcaine—SCN10A—Developmental Biology—VEGFA—prostate cancer	0.000499	0.000513	CbGpPWpGaD
Hexylcaine—SCN1A—Developmental Biology—VEGFA—prostate cancer	0.000499	0.000513	CbGpPWpGaD
Hexylcaine—SCN3A—Developmental Biology—TGFB1—prostate cancer	0.000494	0.000509	CbGpPWpGaD
Hexylcaine—SCN1A—Developmental Biology—STAT3—prostate cancer	0.000494	0.000508	CbGpPWpGaD
Hexylcaine—SCN10A—Developmental Biology—STAT3—prostate cancer	0.000494	0.000508	CbGpPWpGaD
Hexylcaine—SCN5A—Developmental Biology—FGF2—prostate cancer	0.000493	0.000508	CbGpPWpGaD
Hexylcaine—SCN5A—Axon guidance—VEGFA—prostate cancer	0.000491	0.000506	CbGpPWpGaD
Hexylcaine—SCN3A—Developmental Biology—EGFR—prostate cancer	0.000484	0.000499	CbGpPWpGaD
Hexylcaine—SCN10A—Axon guidance—IL6—prostate cancer	0.000483	0.000498	CbGpPWpGaD
Hexylcaine—SCN1A—Axon guidance—IL6—prostate cancer	0.000483	0.000498	CbGpPWpGaD
Hexylcaine—SCN2A—Developmental Biology—TGFB1—prostate cancer	0.000475	0.000489	CbGpPWpGaD
Hexylcaine—SCN5A—Developmental Biology—JAK2—prostate cancer	0.000473	0.000487	CbGpPWpGaD
Hexylcaine—SCN2A—Developmental Biology—EGFR—prostate cancer	0.000465	0.000479	CbGpPWpGaD
Hexylcaine—SCN10A—Developmental Biology—TGFB1—prostate cancer	0.000458	0.000471	CbGpPWpGaD
Hexylcaine—SCN1A—Developmental Biology—TGFB1—prostate cancer	0.000458	0.000471	CbGpPWpGaD
Hexylcaine—SCN3A—Developmental Biology—KRAS—prostate cancer	0.000458	0.000471	CbGpPWpGaD
Hexylcaine—SCN5A—Developmental Biology—ERBB2—prostate cancer	0.000455	0.000469	CbGpPWpGaD
Hexylcaine—SCN1A—Developmental Biology—EGFR—prostate cancer	0.000449	0.000462	CbGpPWpGaD
Hexylcaine—SCN10A—Developmental Biology—EGFR—prostate cancer	0.000449	0.000462	CbGpPWpGaD
Hexylcaine—SCN5A—Axon guidance—EGFR—prostate cancer	0.000442	0.000455	CbGpPWpGaD
Hexylcaine—SCN2A—Developmental Biology—KRAS—prostate cancer	0.00044	0.000453	CbGpPWpGaD
Hexylcaine—SCN10A—Developmental Biology—KRAS—prostate cancer	0.000424	0.000436	CbGpPWpGaD
Hexylcaine—SCN1A—Developmental Biology—KRAS—prostate cancer	0.000424	0.000436	CbGpPWpGaD
Hexylcaine—SCN5A—Axon guidance—KRAS—prostate cancer	0.000418	0.00043	CbGpPWpGaD
Hexylcaine—SCN5A—Developmental Biology—CTNNB1—prostate cancer	0.000398	0.00041	CbGpPWpGaD
Hexylcaine—SCN5A—Developmental Biology—MMP9—prostate cancer	0.00039	0.000402	CbGpPWpGaD
Hexylcaine—SCN3A—Developmental Biology—IL6—prostate cancer	0.000372	0.000383	CbGpPWpGaD
Hexylcaine—SCN5A—Developmental Biology—EP300—prostate cancer	0.00037	0.000381	CbGpPWpGaD
Hexylcaine—SCN5A—Developmental Biology—SRC—prostate cancer	0.00036	0.000371	CbGpPWpGaD
Hexylcaine—SCN2A—Developmental Biology—IL6—prostate cancer	0.000358	0.000368	CbGpPWpGaD
Hexylcaine—SCN5A—Developmental Biology—VEGFA—prostate cancer	0.000351	0.000361	CbGpPWpGaD
Hexylcaine—SCN5A—Developmental Biology—STAT3—prostate cancer	0.000347	0.000357	CbGpPWpGaD
Hexylcaine—SCN1A—Developmental Biology—IL6—prostate cancer	0.000345	0.000355	CbGpPWpGaD
Hexylcaine—SCN10A—Developmental Biology—IL6—prostate cancer	0.000345	0.000355	CbGpPWpGaD
Hexylcaine—SCN3A—Developmental Biology—AKT1—prostate cancer	0.000343	0.000354	CbGpPWpGaD
Hexylcaine—SCN5A—Axon guidance—IL6—prostate cancer	0.00034	0.00035	CbGpPWpGaD
Hexylcaine—SCN2A—Developmental Biology—AKT1—prostate cancer	0.00033	0.00034	CbGpPWpGaD
Hexylcaine—SCN5A—Developmental Biology—TGFB1—prostate cancer	0.000322	0.000331	CbGpPWpGaD
Hexylcaine—SCN1A—Developmental Biology—AKT1—prostate cancer	0.000318	0.000328	CbGpPWpGaD
Hexylcaine—SCN10A—Developmental Biology—AKT1—prostate cancer	0.000318	0.000328	CbGpPWpGaD
Hexylcaine—SCN5A—Developmental Biology—EGFR—prostate cancer	0.000316	0.000325	CbGpPWpGaD
Hexylcaine—SCN5A—Developmental Biology—KRAS—prostate cancer	0.000298	0.000307	CbGpPWpGaD
Hexylcaine—SCN5A—Developmental Biology—IL6—prostate cancer	0.000242	0.00025	CbGpPWpGaD
Hexylcaine—SCN5A—Developmental Biology—AKT1—prostate cancer	0.000224	0.00023	CbGpPWpGaD
